Peer-Reviewed Journal Details
Mandatory Fields
Lord, P,Spiering, R,Aguillon, JC,Anderson, AE,Appel, S,Benitez-Ribas, D,ten Brinke, A,Broere, F,Cools, N,Cuturi, MC,Diboll, J,Geissler, EK,Giannoukakis, N,Gregori, S,van Ham, SM,Lattimer, S,Marshall, L,Harry, RA,Hutchinson, JA,Isaacs, JD,Joosten, I,van Kooten, C,de Cerio, ALD,Nikolic, T,Oral, HB,Sofronic-Milosavljevic, L,Ritter, T,Riquelme, P,Thomson, AW,Trucco, M,Vives-Pi, M,Martinez-Caceres, EM,Hilkens, CMU
2016
August
Peerj
Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies
Published
()
Optional Fields
Cell therapy Minimum information model Antigen-presenting cells Autoimmune disease Transplantation Tolerogenic dendritic cells Regulatory macrophages Reporting guidelines DENDRITIC CELLS DISEASE
4
Cellular therapies, with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation The methodologies for generating tolAPC vary greatly between different laboratories, making it difficult to compare data from different studies; thus constituting a major hurdle for the development of standardised tolAPC therapeutic products. Here we describe an initiative by members of the tolAPC field to generate a minimum information model for tolAPC (MITAP), providing a reporting framework that will make differences and similarities between tolAPC products transparent. In this way, MITAP constitutes a first but important step towards the production of standardised and reproducible tolAPC for clinical application.
10.7717/peerj.2300
Grant Details
Publication Themes